Special Guest · 8:00–8:15 AM PT
?
Special guest
no show: Karen Koch, City of Irvine
Pitches · 8:15–9:30 AM PT
Tesa Medical
Sean Cogan, CEO · scogan@tesamedcorp.com
Tesa develops technology to improve outcomes in ACL and knee ligament surgery by enabling precise tunnel position, graft tension, and fixation—targeting the ~40% of patients unable to return to prior activity level after surgery.
Round
$5M Priced Round @ $11M pre-money
FDA milestone
FDA notification D589661
FDA timeline
510(k) for fixation devices ~90 days from submission (ready to submit; funding needed)
Other groups in round
Orthopedic surgeons, med tech executives, HNW individuals, and Louisiana funds
Traction: 34 human cases completed using reusable device in Australia with KOL group; repeat bookings and positive patient feedback; supports all ACL graft types and fixation device styles plus 10 other knee ligament surgeries.
What they're looking for: Advisors, sales rep references, KOLs, and customer introductions.
Nospharma
Anmol Nagpal, CEO · anmol@nospharma.ca
Nospharma is developing, NOS-01, the first treatment for the $12B Fragile X Syndrome market, the leading genetic cause of intellectual disability
Round
2,000,000 Convertible Note @ $8M post-money (term sheet in hand)
Closed
$725k
FDA milestone
Pre-clincial stage company
FDA timeline
12 months to IND submission / 48-36 months to Phase 2 clinical outcome
Other groups in round
Robin Hood Ventures, HNWI/Angels, Patient Foundation
DD package
yes
Traction: Lead investor secured + 40% round committed
What they're looking for: Introductions to KOLs and advisors (finance or clinical) are welcome
Platform Innovations
Steven T Jones, CEO · sjones@platforminnovations.com
Adjustable Curve Suction Irrigation Accessory to create a curve when used with standard straight metal suction irrigation tips
Round
$3M Priced Round @ $14.5M
Closed
$1.4M
FDA milestone
Launched Product Q1 2024. 510K Exempt Device
FDA timeline
NA
Other groups in round
Serial Stage Venture Partners
DD package
yes
Traction: Over $200,000 in revenue 2025 to date.
What they're looking for: Sales distribution assistance primarily.